Examples of using Lemtrada in English and their translations into Polish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
What you need to know before you are administered LEMTRADA- Infections.
LEMTRADA contains no antimicrobial preservatives
LEMTRADA treatment should be initiated
Any vaccination will need to be given to you at least 6 weeks before starting a LEMTRADA treatment course.
In controlled clinical trials, infusion associated reactions(IARs) were defined as any adverse event occurring during or within 24 hours of LEMTRADA infusion.
LEMTRADA is supplied in a clear, 2 ml glass vial, with a butyl rubber stopper
In clinical trials, patients were pre-treated with 1,000 mg methylprednisolone for the first 3 days of each LEMTRADA treatment course.
Most patients in controlled clinical trials received antihistamines and/or antipyretics before at least one LEMTRADA infusion.
These can be diagnosed from the blood tests that you will be having regularly after LEMTRADA treatment.
Patients should be pre-treated with corticosteroids immediately prior to LEMTRADA administration on each of the first 3 days of any treatment course.
2, and 3 observed in≥0.5% of LEMTRADA 12 mg treated patients.
Study 3(phase 2 study CAMMS223) evaluated the safety and efficacy of LEMTRADA in patients with RRMS over the course of 5 years.
patients receiving LEMTRADA should avoid ingestion of uncooked
generally within one month of LEMTRADA infusion.
Patient Alert Card: For the patient to present to other healthcare providers to alert them to the use of LEMTRADA in this patient.
In controlled clinical trials two MS patients accidentally received up to 60 mg LEMTRADA(i.e., total dose for initial treatment course) in a single infusion and experienced serious reactions headache, rash,
with 92% of these patients testing positive also for antibodies that inhibited LEMTRADA binding in vitro.
What you need to know before you are administered LEMTRADA- Vaccines.
LEMTRADA is indicated for adult patients with relapsing remitting multiple sclerosis(RRMS) with active disease defined by clinical or imaging features see sections 4.4 and 5.1.
Autoimmune thyroid disorders have been observed in an estimated 36% of patients treated with LEMTRADA 12 mg in clinical trials in MS through 48 months following first LEMTRADA exposure.